Search

everythinglearnresearchcommunity

for

Search:↓

Sunlight worsens hair loss; protect scalp.

A rare type of skin cancer with mucosal involvement was partially treated but eventually relapsed.

Contact immunotherapy can cause vitiligo in patients with autoimmune conditions.

T-cell reconstitution after thymus transplantation can cause hair whitening and loss.

Accurate diagnosis of pseudolymphomatous folliculitis is crucial to avoid mistaking it for more serious conditions.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

T-cell patterns in skin help distinguish alopecia areata from androgenetic alopecia.

CD8+ T cells play a key role in graft-versus-host disease in certain mice models.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

The monkey's hair loss was due to an autoimmune disease, not genetics.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

A five-month-old boy with Omenn syndrome successfully recovered after a stem cell transplant with reduced intensity conditioning.

Targeting the protein Caveolin-1 might help treat a type of scarring hair loss called Frontal Fibrosing Alopecia.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

CRAC channels are crucial for the development and function of specialized immune cells, preventing severe inflammation and autoimmune diseases.

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

Hamilton scale imprecise, hair shaft diameter decreases, stem cell transplant regrows hair, ECP ineffective for alopecia areata universalis.

Mice studies show that Protein Phosphatase 2A is crucial for cell growth, development, and disease prevention.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Tight junctions are key for skin protection and controlling what gets absorbed or passes through the skin.

Hair follicle hyperplasia is common in both benign and malignant skin lymphoproliferative disorders, with a proposed new term "pseudolymphomatous adnexitis."

Mice lacking fibromodulin have disrupted healing patterns, leading to abnormal skin repair and scarring.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Alopecia areata involves immune response and gene changes affecting hair loss.

Two mouse mutations cause similar hair loss despite different skin changes.

Two teenage brothers had a rare, treatment-resistant form of female-pattern hair loss with unusual scalp changes.

Contact immunotherapy might help treat various skin conditions, but more research is needed to confirm its safety and effectiveness.